Immune Therapeutics, Inc.
IMUN · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | -$0 | – | – | $5 |
| Short-Term Investments | $0 | – | – | $0 |
| Receivables | $0 | – | – | $0 |
| Inventory | $0 | – | – | $0 |
| Other Curr. Assets | $0 | – | – | $0 |
| Total Curr. Assets | -$0 | – | – | $5 |
| Property Plant & Equip (Net) | $0 | – | – | $0 |
| Goodwill | $0 | – | – | $0 |
| Intangibles | $0 | – | – | $722 |
| Long-Term Investments | $0 | – | – | $0 |
| Tax Assets | $0 | – | – | $0 |
| Other NC Assets | $6 | – | – | $6 |
| Total NC Assets | $6 | – | – | $727 |
| Other Assets | $0 | – | – | $0 |
| Total Assets | $5 | – | – | $732 |
| Liabilities | – | – | – | – |
| Payables | $1,256 | – | – | $1,350 |
| Short-Term Debt | $1,170 | – | – | $1,119 |
| Tax Payable | $0 | – | – | $0 |
| Deferred Revenue | $0 | – | – | -$1,741,324 |
| Other Curr. Liab. | $1,627 | – | – | $1,743,067 |
| Total Curr. Liab. | $5,308 | – | – | $4,212 |
| LT Debt | $0 | – | – | $0 |
| Deferred Rev, NC | $0 | – | – | $0 |
| Deferred Tax Liab, NC | $0 | – | – | $0 |
| Other NC Liab. | $0 | – | – | $0 |
| Total NC Liab. | $0 | – | – | $0 |
| Other Liabilities | $0 | – | – | $0 |
| Cap. Leases | $0 | – | – | $0 |
| Total Liabilities | $5,308 | – | – | $4,212 |
| Equity | – | – | – | – |
| Pref Stock | $0 | – | – | $0 |
| Common Stock | $8 | – | – | $8 |
| Retained Earnings | -$386,112 | – | – | -$384,278 |
| AOCI | $0 | – | – | $0 |
| Other Equity | $380,801 | – | – | $380,789 |
| Total Equity | -$5,303 | – | – | -$3,480 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | – | – | $0 |
| Total Liab. & Tot. Equity | $5 | – | – | $732 |
| Net Debt | $1,170 | $0 | $0 | $1,114 |